Kunzwisisa huwandu hwekugwinya kweropa: kukosha kwakajairika uye hutano

Munyaya yehutano hwezvekurapa, kushanda kweropa rinovhara ropa chinhu chakakosha mukuchengetedza mamiriro emuviri wemunhu. Huwandu hweropa rinovhara ropa, hunowanzo kuyerwa nezviratidzo zvine chekuita nekuvhara ropa, hunoita basa rakakosha pakuongorora hutano hwemuviri wemunhu. Saka, huwandu hwakajairwa hweropa rinovhara ropa chii? Nyaya iyi ine chekuita nekuongororwa nekurapwa kwevarwere vazhinji, uye yakakwezvawo kutariswa kukuru kubva kune nyanzvi dzezvekurapa neveruzhinji.

Kazhinji, zviratidzo zvekuongorora mashandiro ekuvharika kweropa zvinoshandiswa zvakanyanya mukiriniki zvinosanganisira nguva yeprothrombin (PT), nguva yechikamu chethromboplastin yakavhurwa (APTT), nguva yethrombin (TT) uye fibrinogen (FIB).
Mhando dzakajairika dzezviratidzo izvi ndeidzi:
Nguva yeprothrombin (PT) inowanzova pakati pemasekonzi gumi nemana, uye inokosha pakurapa kana ikapfuura mwero wenguva dzose neanopfuura masekonzi matatu;
Nguva yakajairika yeactivated partial thromboplastin time (APTT) imasekondi makumi maviri nemashanu kusvika makumi matatu nemanomwe, uye kana ikadarika nguva yakajairika yekudzora neanopfuura masekondi gumi, inofanira kutorwa zvakakomba;
Nguva yenguva yeropa rinobuda (TT) inotangira pamasekonzi gumi nemaviri kusvika gumi nematanhatu, uye kudarika nguva yekudzora kweropa neanopfuura masekonzi matatu kunoratidza kuti panogona kunge paine zvinhu zvisina kumira zvakanaka;
Huwandu hwe fibrinogen (FIB) hwakajairika huri pakati pe2 ne4g/L.

Zvisinei, zvinofanira kucherechedzwa kuti nekuda kwekusiyana kwenzira dzekuongorora, ma reagents uye zvishandiso zvinoshandiswa nezvipatara zvakasiyana, huwandu hwakajairika hwekugwinya kweropa hunogona kusiyana zvishoma. Saka, huwandu hwakajairika hwekutarisa hunofanirwa kunge hwakavakirwa pafomu remushumo wechipatara uko murwere ari kurapwa.

Kuwanda kweropa risina kujairika kunowanzoenderana nezvirwere zvakasiyana-siyana. Kana kuwanda kweropa kwakakwira zvakanyanya, zvinogona kunge zvichikonzerwa nezvirwere zvakaita se thrombocytosis, polycythemia vera, uye kuvharika kweropa mukati meropa, izvo zvinowedzera kuvharika kweropa uye nokudaro zvinowedzera njodzi ye thrombosis. Pamusoro pezvo, mimwe mishonga yakaita se anticoagulants (heparin, warfarin), antiplatelet drugs (aspirin, clopidogrel), chemotherapy drugs, uye marapirwo akadai se hemodialysis uye extracorporeal membrane oxygenation (ECMO) zvinogonawo kukanganisa mashandiro eropa, zvichikonzera kuvharika kwakanyanya. Kusiyana neizvi, kuvharika kwakanyanya kunogonawo kukonzerwa nekushaikwa kweropa rine ropa, kushomeka kwevhitamini K, thrombocytopenia, kushandiswa kwakanyanya kwe anticoagulants, uye zvirwere zve coagulation factor consumption. Mamiriro aya anogona kukonzera matambudziko eropa uye anogona kukonzera kubuda ropa.

Kune veruzhinji, zvakakosha kunzwisisa huwandu hwehuwandu hwemagadziko eropa uye ruzivo rwakakodzera rwekushanda kwegadziko risina kujairika. Kana huwandu hwemagadziko asina kujairika hukawanikwa panguva yekuongororwa kwemuviri kana kurapwa, chiremba anofanira kubvunzwa nenguva kuti atsanangure chikonzero uye atore matanho akakodzera ekurapa. Panguva imwe chete, kuongororwa kwemuviri nguva dzose uye kuchengetedza mararamiro ane hutano zvakanakawo pakuchengetedza kushanda kwegadziko kwakajairika.

Beijing Succeeder Technology Inc. (kodhi yemasheya: 688338) yave ichibatanidzwa zvakanyanya mubazi rekuongorora ropa kubva payakatangwa muna 2003, uye yakazvipira kuva mutungamiri mubazi iri. Iri muBeijing, kambani iyi ine timu yakasimba yeR&D, yekugadzira nekutengesa, inotarisa pakuvandudza nekushandisa tekinoroji yekuongorora ropa neropa.

Nesimba rayo guru rehunyanzvi, Succeeder yakahwina mapatents makumi mana nemashanu ane mvumo, anosanganisira mapatents gumi nemana ekugadzira zvinhu zvitsva, mapatents gumi nematanhatu emhando yemagetsi uye mapatents ekugadzira gumi nemashanu. Kambani iyi inewo zvitupa zvekunyoresa zvigadzirwa zvemhando yechipiri zvemhando yechitatu, zvitupa zvitatu zvefaira zvemhando yekutanga, uye chitupa cheEU CE chezvigadzirwa gumi nemana, uye yakapasa chitupa cheISO 13485 chehunhu hwekutarisira mhando kuti ive nechokwadi chekuti mhando yechigadzirwa yakanaka uye yakagadzikana.

Succeeder haisi kambani huru yeBeijing Biomedicine Industry Leapfrog Development Project (G20) chete, asi yakabudirirawo kupinda muScience and Technology Innovation Board muna 2020, zvichiita kuti kambani ibudirire zvikuru. Parizvino, kambani iyi yakavaka network yekutengesa munyika yese inobatanidza mazana evamiririri nemahofisi. Zvigadzirwa zvayo zvinotengeswa zvakanaka munzvimbo zhinji dzenyika. Iri kuwedzerawo misika yekune dzimwe nyika uye iri kuramba ichivandudza kukwikwidza kwayo pasi rose.